Business Description
Dian Diagnostics Group Co Ltd
ISIN : CNE1000015N1
Share Class Description:
SZSE:300244: Class ACompare
Compare
Traded in other countries / regions
300244.China IPO Date
2011-07-19Description
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.81 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.55 | |||||
| Debt-to-EBITDA | 4 | |||||
| Interest Coverage | 5.92 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.58 | |||||
| Beneish M-Score | -2.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.8 | |||||
| 3-Year EBITDA Growth Rate | -1.6 | |||||
| 3-Year EPS without NRI Growth Rate | -26.5 | |||||
| 3-Year FCF Growth Rate | 4.2 | |||||
| 3-Year Book Growth Rate | 16.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19 | |||||
| 9-Day RSI | 22.64 | |||||
| 14-Day RSI | 26.74 | |||||
| 6-1 Month Momentum % | -17.01 | |||||
| 12-1 Month Momentum % | -33.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.82 | |||||
| Quick Ratio | 2.51 | |||||
| Cash Ratio | 0.69 | |||||
| Days Inventory | 59.55 | |||||
| Days Sales Outstanding | 258.14 | |||||
| Days Payable | 98.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.36 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| 3-Year Dividend Growth Rate | 16 | |||||
| Forward Dividend Yield % | 1.36 | |||||
| 5-Year Yield-on-Cost % | 12.4 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 6.25 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.29 | |||||
| Operating Margin % | 11.07 | |||||
| Net Margin % | 2.29 | |||||
| FCF Margin % | 9.1 | |||||
| ROE % | 4.03 | |||||
| ROA % | 1.56 | |||||
| ROIC % | 8.86 | |||||
| ROC (Joel Greenblatt) % | 11.08 | |||||
| ROCE % | 7.76 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29 | |||||
| PE Ratio without NRI | 14.06 | |||||
| Shiller PE Ratio | 15.31 | |||||
| PEG Ratio | 0.87 | |||||
| PS Ratio | 0.67 | |||||
| PB Ratio | 1.18 | |||||
| Price-to-Tangible-Book | 1.34 | |||||
| Price-to-Free-Cash-Flow | 7.23 | |||||
| Price-to-Operating-Cash-Flow | 4.6 | |||||
| EV-to-EBIT | 9.22 | |||||
| EV-to-EBITDA | 9.22 | |||||
| EV-to-Revenue | 0.72 | |||||
| EV-to-FCF | 8.06 | |||||
| Price-to-Projected-FCF | 0.58 | |||||
| Price-to-DCF (Earnings Based) | 0.45 | |||||
| Price-to-DCF (FCF Based) | 0.63 | |||||
| Price-to-Median-PS-Value | 0.3 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.64 | |||||
| Price-to-Graham-Number | 0.92 | |||||
| Price-to-Net-Current-Asset-Value | 2.59 | |||||
| Earnings Yield (Greenblatt) % | 10.85 | |||||
| FCF Yield % | 13.66 | |||||
| Forward Rate of Return (Yacktman) % | 17.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dian Diagnostics Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 13,408.32 | ||
| EPS (TTM) (Â¥) | 0.491 | ||
| Beta | 0.7 | ||
| Volatility % | 37.31 | ||
| 14-Day RSI | 26.74 | ||
| 14-Day ATR (Â¥) | 0.611436 | ||
| 20-Day SMA (Â¥) | 15.8665 | ||
| 12-1 Month Momentum % | -33.54 | ||
| 52-Week Range (Â¥) | 14.02 - 27.98 | ||
| Shares Outstanding (Mil) | 626.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dian Diagnostics Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dian Diagnostics Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dian Diagnostics Group Co Ltd Frequently Asked Questions
What is Dian Diagnostics Group Co Ltd(SZSE:300244)'s stock price today?
The current price of SZSE:300244 is ¥14.24. The 52 week high of SZSE:300244 is ¥27.98 and 52 week low is ¥14.02.
When is next earnings date of Dian Diagnostics Group Co Ltd(SZSE:300244)?
The next earnings date of Dian Diagnostics Group Co Ltd(SZSE:300244) is .
Does Dian Diagnostics Group Co Ltd(SZSE:300244) pay dividends? If so, how much?
The Dividend Yield %  of Dian Diagnostics Group Co Ltd(SZSE:300244) is 1.36% (As of Today), Highest Dividend Payout Ratio of Dian Diagnostics Group Co Ltd(SZSE:300244) was 0.42. The lowest was 0.04. And the median was 0.09. The  Forward Dividend Yield % of Dian Diagnostics Group Co Ltd(SZSE:300244) is 1.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers